AU-2020362194-B2 - A pyrazolopyrimidine derivative as a HCK inhibitor for use in therapy, in particular MYD88 mutated diseases
AU2020362194B2AU 2020362194 B2AU2020362194 B2AU 2020362194B2AU-2020362194-B2
Inventors
- BUHRLAGE, SARA JEAN
- GRAY, NATHANAEL S.
- TAN, LI
- TREON, STEVEN P.
- WANG, JINHUA
- YANG, GUANG
Assignees
- DANA-FARBER CANCER INSTITUTE, INC.
Dates
- Publication Date
- 20260507
- Application Date
- 20201007
- Priority Date
- 20191008